Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Woodcock defends FDA's response to Omicron before Senate health committee
4 years ago
FDA+
Coronavirus
Pfizer lays off hundreds of US sales rep as fewer in-person meetings expected to remain permanent
4 years ago
Pharma
Marketing
CMS to restrict coverage of Biogen's controversial Alzheimer's drug to only clinical trials
4 years ago
Pharma
Micro-influencers with a major platform: Are they the next big thing in pharma marketing?
4 years ago
Marketing
MarketingRx roundup: Neurocrine amps tardive dyskinesia campaign; FDA study finds animation has little effect in DTC ...
4 years ago
Pharma
Marketing
Endo pivots from NFL star John Elway to real patients in Dupuytren’s contracture awareness ads
4 years ago
Pharma
Marketing
Data analytics looms large as PharmStars digital health accelerator wraps first 'PharmU' startup class
4 years ago
Pharma
Marketing
Can virus-like particles unleash a new wave of CRISPR treatments?; Fosun Pharma and Insilico team up in AI discovery ...
4 years ago
News Briefing
Korean conglomerate SK takes out stake in cell and gene therapy CDMO with plans for a major hiring spree outside ...
4 years ago
Cell/Gene Tx
Manufacturing
Pfizer's hot start to the new year continues with licensing deal for mysterious biotech's solid tumor bispecifics
4 years ago
Deals
Bob Nelsen, Anne Wojcicki join $20M round for longevity startup hoping to slow down aging of the ovary
4 years ago
Financing
Startups
Low-profile Shanghai-based CDMO secures high profile investors for 9-digit Series C
4 years ago
Financing
Manufacturing
Covid-19 roundup: US buys more of the only antibody that works against Omicron; BioNTech taps AI to detect new ...
4 years ago
Coronavirus
Recall report: Another month, another issue with NDMA
4 years ago
Manufacturing
After a year of big investments, Recipharm sells off assets in Europe
4 years ago
Manufacturing
Busy Amgen swings another deal, this time with RNA drugging player Arrakis for 'several billion'
4 years ago
Deals
A new AI startup has emerged, and Pfizer likes what it sees
4 years ago
Financing
Startups
Sarepta's second shot at showing its Duchenne gene therapy delivers positive data but underwhelms — shares tumble
4 years ago
R&D
Cell/Gene Tx
In historic first, surgeons transplant a genetically modified pig heart into a dying patient
4 years ago
Discovery
7 blockbusters: Analysts spotlight 2022’s crop of drugs most likely to win top marketing status — 2 drugs ...
4 years ago
R&D
Pharma
Amicus gets hit with an 'unexpected' setback on a gene therapy tapped to lead $600M SPAC spinout
4 years ago
Bioregnum
Cell/Gene Tx
Pharma brands spent $3.9B on TV ads in 2021, led by Sanofi, Regeneron’s Dupixent and Novo Nordisk’s Rybelsus
4 years ago
Pharma
Marketing
Health takes center stage at annual CES tech bash with advanced wearables, telehealth deals and latest in Covid ...
4 years ago
Pharma
Marketing
Selecta turns to synbio player for $1.1B capsid deal; BioNTech signs $790M immunotherapy deal
4 years ago
News Briefing
First page
Previous page
600
601
602
603
604
605
606
Next page
Last page